Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib

Wenn, K.; Lange, T.; Brümmendorf, Tim Henrik; Ziegler, Patrick; Koschmieder, Steffen; Hochhaus, A.; Wilop, S.; Giles, F. J.; Hasenbank, C.; Frank, O.; Tomala, L.; Vankann, L.; Beier, F.; Müller, M. C.

doi:1476-5551

%0 Journal Article
%A Wenn, K.
%A Tomala, L.
%A Wilop, S.
%A Vankann, L.
%A Hasenbank, C.
%A Frank, O.
%A Hochhaus, A.
%A Giles, F. J.
%A Lange, T.
%A Müller, M. C.
%A Koschmieder, Steffen
%A Beier, F.
%A Ziegler, Patrick
%A Brümmendorf, Tim Henrik
%T Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib
%J Leukemia : normal and malignant hemopoiesis
%V 29
%N 12
%@ 0887-6924
%C Basingstoke
%I Nature Publishing Group
%M RWTH-CONV-092106
%P 2402-2404
%D 2015
%F PUB:(DE-HGF)16
%9 Journal Article
%U <Go to ISI:>//WOS:000366393900016
%$ pmid:26369986
%R 10.1038/leu.2015.245
%U https://publications.rwth-aachen.de/record/567734

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines